Metacrine Receives $25,616,649 New Round

  • Feed Type
  • Date
    11/10/2016
  • Company Name
    Metacrine
  • Mailing Address
    12780 El Camino Real San Diego, CA 92130 USA
  • Company Description
    Metacrine is a biotech company founded in 2015 on technology licensed from the laboratory of Dr. Ronald Evans, a world leader in nuclear hormone receptors and Howard Hughes Medical Institute Investigator at the Salk Institute.
  • Website
    http://www.metacrine.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $25,616,649
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 20 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy